MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan EP News Bureau Oct 27, 2025 The agreement grants MEDINET rights to develop and commercialise Stempeucel for CLTI indication in Japan, with manufacturing to…
